We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sensyne Health Plc | LSE:SENS | London | Ordinary Share | GB00BYV3J755 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.35 | 0.30 | 0.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
20/8/2020 08:47 | I think the owner is an issue, totally agree. PWC and the settling of the dismissal help. I also think, there is only one way he releases any real money from his massive holdings - via a sale; he won't be allowed to drip sell for reasons you mention. | 2theduke | |
20/8/2020 08:40 | Didn't last results show loss of £10m for H1 ? Pretty sure cash burn rate was a scary £20m p.a. Also how can anyone trust Drayson after he appointed a CFO he later thinks was not up to the job? | the stigologist | |
20/8/2020 08:31 | At 73p its £72m market cap? versus a cash balance of c£30m, a low cash burn of c£3m (exc. increasing revenues). It is in the right space of tech and bio, with a covid upside. It is reporting growing revenues, capturing NHS data, and growing in the US. 73p is clearly no where near a fair value vs. comps out there. It was held down for clear and obvious reasons, but if it was not for that, or say this was a US listed company with the covid exposure it has, this would be multiples higher. 73p looks like a fair in to me, good luck. DYOR | 2theduke | |
20/8/2020 08:25 | Bought at 73p. Hope for the bounce | deanmatlazin | |
20/8/2020 07:54 | Well done to those who bought in before the bounce. I missed this one (too cautious) but still don't intend to join the party for a while yet. | zulu_principle | |
19/8/2020 21:42 | Due diligence is overrated | edwardt | |
19/8/2020 19:12 | Missed this one. Due to pandemic...there will be no face to face consultation in U.K. or in US. The best way to monitor patient’s blood sugar is by linking the result straight to the consultant. I can see the demand is going up due to Covid. Will try to get in tomorrow morning. | deanmatlazin | |
19/8/2020 17:58 | Anybody have any idea how high this can go tomorrow? | zen12 | |
19/8/2020 17:53 | Well, happy with my research on this one. Just in time :-/ | 2theduke | |
19/8/2020 16:52 | Mid price is now showing 84p so up 75%. Pleased I stuck with them and averaged down. Above break even for me. Hope everyone else is doing well and the price stabilises | billy3 | |
19/8/2020 16:40 | Up 54% on yesterday’s closing bid. Happy with that. | billy3 | |
19/8/2020 15:56 | I just feel sorry for Woodford investors. The regulator should be ashamed of themselves. | edwardt | |
19/8/2020 15:51 | They had to let it go at some stage. | tez123 | |
19/8/2020 14:30 | Held back from buying originally until these went below 100p & now at an average of 40p. Will they go past 100p on way back up? | mrc2u | |
19/8/2020 14:15 | Now we are motoring | edwardt | |
19/8/2020 09:03 | So looking in to the share holding overhang; it would appear Acacia has purchased most of Links (the newco handling Woodford) bioscience shares. It's not updated in shareholder comments yet on the website (which is dated march 30th), but the SEC listing by Acacia implies this is the case, you can read it here where Sens is noted as a takeover portfolio company. hxxps://sec.report/D All in all the news flow certainly seems to be turning positive, and if the overhand is done, revenues starting to grow, and considerable pick up in App usage given Covid, this certainly looks like it will get some momentum. DYOR as I'm just really starting mine! | 2theduke | |
19/8/2020 09:00 | Bought a wee tranche | volsung | |
19/8/2020 08:51 | hxxps://www.sensyneh | billy3 | |
19/8/2020 08:35 | Nice announcement! | edwardt | |
18/8/2020 13:57 | i agree with your last sentence! | edwardt | |
18/8/2020 10:08 | That’s not really putting it in to context is it ? That’s just saying the share price is the same. Context is reading the price based on current information too. It depends when you bought, what the results are, what progress has been made since May, what’s the position with the overhang. The price still isn’t great but it’s better than 28p | billy3 | |
18/8/2020 09:49 | context. we are back to where we were in may. | edwardt | |
18/8/2020 09:43 | Yes I agree. Is the overhang gone then ? Some announcements with results ? Pleased that I averaged down at 28p. That’s heading for doubling since purchase. Still a way to go to break even but moving in the right direction. | billy3 | |
18/8/2020 09:09 | Quite an steady uptick at SENS today, almost right from the off. Currently the lowest ask on show is 47p and only a smidgen less is now being paid. Difficult not to think that something positive is going on here. f | fillipe |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions